Tag Archives: Oral colostrum macrophage-activating factor

Colostrum MAF – promising therapy for CFS

 Research abstract: Background: Gc protein-derived macrophage-activating factor (GcMAF) immunotherapy has been steadily advancing over the last two decades. Oral colostrum macrophage-activating factor (MAF) produced from bovine colostrum has shown high macrophage phagocytic activity. GcMAF-based immunotherapy has a wide application for … Continue reading

Posted in News | Tagged , , , | Comments Off on Colostrum MAF – promising therapy for CFS